These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Clinical and pharmacokinetic concerns of 24-hour dosing with theophylline. Weinberger M Ann Allergy; 1986 Jan; 56(1):2-12. PubMed ID: 3511775 [TBL] [Abstract][Full Text] [Related]
5. Clinical pharmacology of theophylline in children. Berdel D; Heimann G Br J Clin Pract Suppl; 1984; 35():29-36. PubMed ID: 6433955 [No Abstract] [Full Text] [Related]
6. [Clinical pharmacology of theophylline in the treatment of asthma]. Cuena Boy R; Honorato Pérez JM; Azanza Perea JR Rev Med Univ Navarra; 1982 Sep; 26(3):175-80. PubMed ID: 7170535 [No Abstract] [Full Text] [Related]
7. [Determination of theophylline concentration in serum and saliva]. Reinhardt D; Becker B Internist (Berl); 1982 Dec; 23(12):725-7. PubMed ID: 6761301 [No Abstract] [Full Text] [Related]
8. Problems with generic theophylline and indiscriminate brand switching. Klein GL Ann Allergy; 1987 May; 58(5):350-2. PubMed ID: 3578929 [TBL] [Abstract][Full Text] [Related]
9. [Theophylline. A new look at an old drug]. Zugić M; Varagić VM Srp Arh Celok Lek; 1982 Feb; 110(2):211-31. PubMed ID: 7157077 [No Abstract] [Full Text] [Related]
10. Dose-dependent pharmacokinetics with single daily dose slow release theophylline in patients with chronic lung disease. Butcher MA; Frazer LA; Reddel HK; Marlin GE Br J Clin Pharmacol; 1982 Feb; 13(2):241-3. PubMed ID: 7059426 [No Abstract] [Full Text] [Related]
12. Comparison of three methods for estimating theophylline pharmacokinetics. Coleman RW; Hedberg RL Clin Pharm; 1983; 2(2):148-52. PubMed ID: 6688390 [No Abstract] [Full Text] [Related]
13. Abnormal absorption of a sustained-release theophylline preparation. Newman LJ; Richards W; Church JA; Borzy MS Ann Allergy; 1980 Aug; 45(2):95-6. PubMed ID: 7406253 [No Abstract] [Full Text] [Related]
14. Studies on the absorption kinetics of theophylline in the steady state, following multiple oral dosing of a sustained-release theophylline tablet formation to asthmatic patients. Takagi K; Hasegawa T; Ogura Y; Satake T; Mizukami Y Chem Pharm Bull (Tokyo); 1986 Sep; 34(9):3894-9. PubMed ID: 3815610 [No Abstract] [Full Text] [Related]
15. A pharmacokinetic approach to the use of theophylline in status asthmaticus. Cohen RM Ann Allergy; 1985 Jan; 54(1):1-11. PubMed ID: 3881058 [No Abstract] [Full Text] [Related]
17. Theophylline for chronic asthma: rationale for treatment, product selection, and dosage schedule. Weinberger M; Hendeles L Pediatr Pharmacol (New York); 1983; 3(3-4):273-85. PubMed ID: 6429620 [TBL] [Abstract][Full Text] [Related]
18. [Peculiarities of the pharmacokinetics and pharmacodynamics of theophylline in children]. Berdel D; Heimann G Wien Klin Wochenschr; 1984 Aug; 96(16):616-21. PubMed ID: 6516414 [TBL] [Abstract][Full Text] [Related]
19. Theophylline absorption in young asthmatic children receiving sustained-release formulations. Haltom JR; Szefler SJ J Pediatr; 1985 Nov; 107(5):805-10. PubMed ID: 4056986 [TBL] [Abstract][Full Text] [Related]
20. [Current problems in the therapeutic use of theophylline]. Bogdan M Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1989; 41(1):15-27. PubMed ID: 2573921 [No Abstract] [Full Text] [Related] [Next] [New Search]